Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Africa
Kathryn M. Chu, Andrew M. Boulle, Nathan Ford et al. · 2010
Read Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Africa by Kathryn M. Chu, Andrew M. Boulle, Nathan Ford et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009183.txt.
Description
Kathryn Chu and co-authors published this clinical study in PLOS ONE in 2010. It follows HIV patients in a primary care treatment program in South Africa. At the time, most African programs used a fixed-dose drug mix containing nevirapine. Doctors worried that nevirapine could damage the liver early in treatment.
The team measured how often early liver harm occurred in the program. They also looked for patient traits that raised the risk, and counted deaths linked to the damage. Such numbers matter because programs had to weigh nevirapine's benefits against its dangers. The findings helped clinicians decide who needed closer liver checks when starting treatment.
Catalog record
| CREATOR | Kathryn M. Chu, Andrew M. Boulle, Nathan Ford et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009183